News for hackers. Stuff that matters.

A comment on Mylan’s EpiPen price hike was a scheme to stifle competition, rival claims. Parent comment

Re:Mylan’s EpiPen price hike was a scheme to stifle competit... by CPLX on Wednesday April 26, 2017 @10:34AM (#14203305)
> The same is true for EpiPen: it's their inaction you condemn, not action.

Your claim is factually incorrect. The issue here is specific, purposeful, anticompetitive behavior.

[ Parent | on HN ]

There are no comments on this comment yet.